Vericel (VCEL) Current Leases (2019 - 2026)
Vericel (VCEL) reported Current Leases of $14.1 million for Q1 2026, up 25.98% on a YoY basis from $11.2 million in Q1 2025, and up 0.67% sequentially from $14.0 million in Q4 2025.
Vericel (VCEL) Current Leases (2019 - 2026) Analysis & Trends
Vericel (VCEL) has 8 years of Current Leases data on file, last reported at $14.1 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 25.98% year-over-year to $14.1 million; the trailing twelve-month figure through Mar 2026 stood at $14.1 million (up 25.98% YoY), and the FY2025 full-year result was $14.0 million, up 50.9% from the prior year.
- Current Leases rose to $14.1 million in Q1 2026, from $14.0 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $14.1 million in Q1 2026 to a low of $3.2 million in Q2 2022.
- A 5-year average of $7.9 million and a median of $6.2 million in 2023 frame the typical range for Current Leases.
- Across the five-year window, Current Leases sank 31.55% in 2022 and jumped 137.49% in 2025, its largest moves.
- Tracing VCEL's Current Leases over 5 years: stood at $4.3 million in 2022, then jumped by 43.82% to $6.2 million in 2023, then jumped by 49.62% to $9.3 million in 2024, then soared by 50.9% to $14.0 million in 2025, then gained by 0.67% to $14.1 million in 2026.
- Business Quant data shows VCEL's Current Leases at $14.1 million in Q1 2026, $14.0 million in Q4 2025, and $13.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 14.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.06 Mn |
| Dec 31, 2025 | 13.97 Mn |
| Sep 30, 2025 | 13.85 Mn |
| Jun 30, 2025 | 13.75 Mn |
| Mar 31, 2025 | 11.16 Mn |
| Dec 31, 2024 | 9.26 Mn |
| Sep 30, 2024 | 6.12 Mn |
| Jun 30, 2024 | 5.79 Mn |
| Mar 31, 2024 | 6.01 Mn |
| Dec 31, 2023 | 6.19 Mn |
| Sep 30, 2023 | 7.27 Mn |
| Jun 30, 2023 | 7.22 Mn |
| Mar 31, 2023 | 4.50 Mn |
| Dec 31, 2022 | 4.30 Mn |
| Sep 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 3.16 Mn |
| Mar 31, 2022 | 3.19 Mn |
| Dec 31, 2021 | 2.95 Mn |
| Sep 30, 2021 | 2.28 Mn |
| Jun 30, 2021 | 4.61 Mn |